CD44 is involved in CXCL-12 induced acute myeloid leukemia HL-60 cell polarity

Biocell

Volumn 34, Issue 2, 2010, Pages 91-94

  Zhou, Liping ^a   Guo, Xiaolin ^a   Ba, Jing ^a   Zhao, Lianshuang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cell migration; Hyaluronic acid; Lamellipodia formation; Uropod formation

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; STROMAL CELL DERIVED FACTOR 1; CHEMOKINE RECEPTOR CXCR4; CXCL12 PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CELL MIGRATION; CELL POLARITY; CELLS AND CELL COMPONENTS; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; LAMELLIPODIUM; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UROPOD; ANIMAL; CELL MOTION; CELL STRAIN HL 60; CELL SURFACE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

UROPODA;

ANIMALS; ANTIGENS, CD44; CELL MOVEMENT; CELL POLARITY; CELL SURFACE EXTENSIONS; CHEMOKINE CXCL12; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; RECEPTORS, CXCR4;

EID: 78349257386     PISSN: 03279545     EISSN: 16675746     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC (1997). The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to the peripheral blood. Journal of Experimental Medicine 185: 111-120.
2. Avigdor A, Goichberg P, Shivtiel S, Dar A, Peled A, Samira S, Kollet O, Hershkoviz R, Alon R, Hardan I, Ben-Hur H, Naor D, Nagler A, Lapidot T (2004). CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/ progenitor cells to bone marrow. Blood 103: 2981-2989.
3. Burger JA, Kipps TJ (2006). CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107: 1761-1767.
4. Burger JA, Burkle A (2007). The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target. Bristish Journal of Haematology 137: 288-296.
5. Brown KL, Birkenhead D, Lai JC, Li L, Li R, Johnson P (2005). Regulation of hyaluronan binding by F-actin and colocalization of CD44 and phosphorylated ezrin/radixin/moesin (ERM) proteins in myeloid cells. Experimental Cell Research 303: 400-414.
6. Bourguignon LY, Singleton PA, Zhu H, Diedrich F (2003). Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. Journal of Biological Chemistry 278: 29420-29434.
7. Charrad RS, Gadhoum Z, Qi J, Glachant A, Allouche M, Jasmin C, Chomienne C, Smadja-Joffe F (2002). Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood 99: 290-299.
8. Gieryng A, Bogunia-Kubik K (2007). The role of the SDF-1-CXCR4 axis in hematopoiesis and the mobilization of hematopoietic stem cells to peripheral blood. Postpy higieny i medycyny do wiadczalnej 61: 369-383.
9. Gadhoum Z, Delaunay J, Maquarre E, Durand L, Lancereaux V, Qi J, Robert-Lezenes J, Chomienne C, Smadja-Joffe F (2004). The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells. Leukemia & Lymphoma 45:1 501-510.
10. Haynes BF, Telen MJ, Hale LP, Denning SM (1989). CD44--a molecule involved in leukocyte adherence and T-cell activation. Immunology Today 10: 423-428.
11. Karnoub AE, Weinberg RA (2006-2007). Chemokine networks and breast cancer metastasis. Breast Disease 26: 75-85.
12. Lee JH, Katakai T, Hara T, Gonda H, Sugai M, Shimizu A (2004). Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation. Journal of Cell Biology 167: 327-337.
13. Pals ST, Koopman G, Heider KH, Griffioen A, Adolf GR, Van den Berg F, Ponta H, Herrlich P, Horst E (1993). CD44 splice variants: expression during lymphocyte activation and tumor progression. Behring Institute Mitteilungen 92: 273-277.
14. Slevin M, Krupinski J, Gaffney J, Matou S, West D, Delisser H, Savani RC, Kumar S (2007). Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biology 26: 58-68.
15. Tavor S, Petit I, Porozov S, Avigdor A, Dar A, Leider-Trejo L, Shemtov N, Deutsch V, Naparstek E, Nagler A, Lapidot T (2004). CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice. Cancer Research 64: 2817-2824.
16. Wood BL (2007). Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia. Clinical & Laboratory Medicine 27: 551-575.
17. Wang J, Loberg R, Taichman RS (2006). The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Reviews 25: 573-587.